ArticleInternal medicine (Tokyo, Japan)2017

Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis.

Megumi Koshiishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.